col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: NeurologĂ­a (English Edition)
  original article Date Title Authors   All Authors
1 [GO] 2021―Jun―05 Three-month functional prognosis of patients hospitalised due to acute ischaemic stroke in Aragon: regional analysis of the impact of COVID-19 H. Tejada Meza, Á. Lambea Gil, C. Villar Yus, C. Pérez Lázaro, M.P. Navarro Pérez, I. Campello Morer, et al. (+11)
2 [GO] 2021―Jun―01 SARS-CoV-2 infection and seroprevalence in patients with multiple sclerosis R. Piñar Morales, M.A. Ramírez Rivas, F.J. Barrero Hernández
3 [GO] 2021―May―29 Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination
4 [GO] 2021―Feb―21 Relation between COVID-19 and Guillain-Barre syndrome in adults. Systematic review F. Araya-Quintanilla, I. Valdés-Orrego, H. Gutiérrez-Espinoza
5 [GO] 2021―Feb―11 Encephalopathy and encephalitis during acute SARS-CoV-2 infection. Spanish Society of Neurology COVID-19 Registry M.J. Abenza Abildúa, S. Atienza, G. Carvalho Monteiro, M.E. Erro Aguirre, L. Imaz Aguayo, E. Freire Álvarez, et al. (+9)
6 [GO] 2021―Feb―07 Impact of the COVID-19 pandemic on a cohort of ALS patients in Catalonia B. Bertran Recasens, M. Povedano Panadés, M.A. Rubio
7 [GO] 2021―Feb―05 Isolated syncope as a form of presentation of COVID-19 infection I. Hernandez Pérez, B. Talavera de la Esperanza, G. Valle Peñacoba, D. Garcia Azorin
8 [GO] 2021―Feb―05 Substance P, proinflammatory cytokines, transient receptor potential vanilloid subtype 1 and COVID-19: a working hypothesis E.E. Aguirre-Siancas, E. Colona-Vallejos, E. Ruiz-Ramirez, M. Becerra-Bravo, L. Alzamora-Gonzales
9 [GO] 2020―Dec―16 COVID-19 and the forgotten pandemic: Follow-up of neurocognitive disorders during lockdown in Argentina M. Sorbara, H.G. Graviotto, G.M. Lage-Ruiz, C.M. Turizo-Rodriguez, L.A. Sotelo-López, A. Serra, et al. (+5)
10 [GO] 2020―Dec―15 Brain inflammatory thrombogenic vasculopathy related with SARS-CoV-2 infection J. Porta-Etessam, M. Yus, N. González García, A. Valcarcel, J. Barrado-Cuchillo, J. Pérez-Somarriba
11 [GO] 2020―Oct―30 Social and professional consequences of COVID-19 lockdown in patients with multiple sclerosis from 2 very different populations G.-X. Zhang, C. Sanabria, D. Martinez, W.-T. Zhang, S.-S. Gao, A. Alemán, et al. (+4)
12 [GO] 2020―Oct―09 Neurological complications in critical patients with COVID-19 M.J. Abenza-Abildúa, M.T. Ramírez-Prieto, R. Moreno-Zabaleta, N. Arenas-Valls, M.A. Salvador-Maya, C. Algarra-Lucas, et al. (+18)
13 [GO] 2020―Oct―09 Relevance of neuroimaging in publications on COVID-19 and stroke J.P. Martínez-Barbero, P. Tomás-Muñoz, R. Martínez-Moreno
14 [GO] 2020―Oct―09 Encefalitis anti-NMDA-R secundaria a infección por SARS-CoV-2 Anti-NMDA receptor encephalitis secondary to SARS-CoV-2 infection G. Alvarez Bravo, L. RamióTorrentà
15 [GO] 2020―Oct―09 Standard headache and neuralgia treatments and SARS-CoV-2: opinion of the Spanish Society of Neurology’s Headache Study Group N. Morollón, R. Belvís, A. De Dios, N. Pagès, C. González-Oria, G. Latorre, S. Santos-Lasaosa
16 [GO] 2020―Oct―08 Smell and taste disorders in Spanish patients with mild COVID-19 J. Barón-Sánchez, C. Santiago, G. Goizueta-San Martín, R. Arca, R. Fernández
17 [GO] 2020―Oct―08 Relation between COVID-19 and Guillain-Barré syndrome in adults: A systematic review LM Trujillo Gittermann, SN Valenzuela Feris, A von Oetinger Giacoman
18 [GO] 2020―Oct―08 Convulsive status epilepticus as a possible symptom of COVID-19 in a patient with intellectual disability and autistic spectrum disorder C. Peña-Salazar, M. López Cuiña, V. Chavarría, B. Robles Olmo
19 [GO] 2020―Oct―08 Therapeutic approaches to multiple sclerosis in Central America and the Caribbean during the COVID-19 pandemic V.M. Rivera, F. Gracia, A. Díaz
20 [GO] 2020―Oct―08 Associated posterior reversible encephalopathy syndrome (PRES) to SARS-CoV-2. Case report L. Ordoñez-Boschetti, C.M. Torres-Romero, M.J. Ortiz De Leo
21 [GO] 2020―Oct―08 Guillain - Barré syndrome as the first manifestation of SARS-CoV-2 infection O. Barrachina-Esteve, A. Palau Domínguez, I. Hidalgo Torrico, M.L. Viguera Martinez
22 [GO] 2020―Oct―07 Case fatality of COVID-19 in patients with neurodegenerative dementia JA Reyes-Bueno, N Mena-Vázquez, T Ojea-Ortega, MM Gonzalez-Sotomayor, P Cabezudo-Garcia, NL Ciano-Petersen, et al. (+3)
23 [GO] 2020―Oct―07 Myopathy associated with serious SARS-CoV-2 infection M.J. Abenza Abildúa, M.T. Ramírez Prieto, R. Moreno Zabaleta, C. Algarra Lucas, C. Pérez López
24 [GO] 2020―Sep―06 Erratum to ‘‘Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm’’ [Neurologia. 2020;35(6):357-362] G. Valero-López, E. Carreón-Guarnizo, R. Hernández-Clares, F. Iniesta-Martínez, J. Jiménez-Veiga, A. Moreno-Docon, et al. (+5)
25 [GO] 2020―Jul―12 Tremor and ataxia in COVID-19 A.M. Diezma-Martín, M.I. Morales-Casado, N. García Alvarado, A. Vadillo Bermejo, N. López-Ariztegui, M.A. Sepúlveda Berrocal
26 [GO] 2020―Jul―12 Guillain-Barré syndrome associated with SARS-CoV-2 infection. Comments after 16 published cases C. Guijarro-Castro, M. Rosón-González, A. Abreu, A. García-Arratibel, M. Ochoa-Mulas
27 [GO] 2020―Jul―12 Emergency implementation of a teleneurology service at the neuromuscular diseases unit of Hospital Regional de Málaga during the SARS-CoV-2 pandemic J. Romero-Imbroda, V. Reyes-Garrido, N.L. Ciano-Petersen, P.J. Serrano-Castro
28 [GO] 2020―Jul―12 The future of neurorehabilitation after the SARS-CoV-2 pandemic A. Juárez-Belaúnde, C. Colomer Font, S. Laxe, M. Ríos-Lago, J. Ferri Campos
29 [GO] 2020―Jul―04 Impact of the COVID-19 pandemic on headache management in Spain: an analysis of the current situation and future perspectives Alba López-Bravo, David García-Azorín, Roberto Belvís, Carmen González-Oria, Germán Latorre, Sonia Santos-Lasaosa, Ángel Luis Guerrero-Peral
30 [GO] 2020―Jul―04 Impact of the COVID-19 pandemic on the organisation of stroke care. Madrid Stroke Care Plan B. Fuentes, M. Alonso de Leciñana, P. Calleja-Castaño, J. Carneado-Ruiz, J. Egido-Herrero, A. Gil-Núñez, et al. (+8)
31 [GO] 2020―Jul―04 Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: safety algorithm Gabriel Valero-López, Ester Carreón-Guarnizo, Rocio Hernández-Clares, Francisca Iniesta-Martínez, Judith Jiménez-Veiga, Antonio Moreno-Docon, et al. (+3)
32 [GO] 2020―Jun―11 The role of scientific journal editors during the COVID-19 pandemic J. Matias-Guiu
33 [GO] 2020―Jun―04 COVID-19 and concomitant neurological infections V. Romero Cantero, S. Moreno Pulido, M. Duque Holgado, I. Casado Naranjo
34 [GO] 2020―Jun―04 OnabotulinumtoxinA infiltration and nerve blocks in patients with headache and neuralgia: safety recommendations to prevent SARS-CoV-2 infection S. Santos-Lasaosa, J. Porta-Etessam
35 [GO] 2020―May―29 Stroke as a complication and prognostic factor of COVID-19 J.M. Trejo Gabriel y Galán
36 [GO] 2020―May―28 Ischaemic stroke and SARS-CoV-2 infection: a causal or incidental association? J.M. Barrios-López, I. Rego-García, C. Muñoz Martínez, J.C. Romero-Fábrega, M. Rivero Rodríguez, J.A. Ruiz Giménez, et al. (+3)
37 [GO] 2020―May―21 Neurological infections during the COVID-19 epidemic R. López-Blanco, R. Cazorla-Garcia, N. Barbero-Bordallo, J. Fernández-Ferro
38 [GO] 2020―May―21 The epilepsy unit during the COVID-19 epidemic: The role of telemedicine and the effects of confinement on patients with epilepsy V. Hernando-Requejo, N. Huertas-González, J. Lapeña-Motilva, G. Ogando-Durán
39 [GO] 2020―May―21 Will neurological care change over the next 5 years due to the COVID-19 pandemic? Key informant consensus survey J. Matías-Guiu, J.A. Matias-Guiu, J. Alvarez-Sabin, J. Ramon Ara, J. Arenillas, I. Casado-Naranjo, et al. (+9)
40 [GO] 2020―May―21 Report of a patient with neurological symptoms as the sole manifestation of SARS-CoV-2 infection S. Escalada Pellitero, L. Garriga Ferrer-Bergua
41 [GO] 2020―May―11 Neurology during the pandemic. Is COVID-19 changing the organisation of Neurology Departments? F.J. Hernández Ramos, A. Palomino García, M.D. Jiménez Hernández
42 [GO] 2020―May―11 Acute stroke care during the COVID-19 pandemic. Ictus Madrid Program recommendations J. Rodríguez-Pardo, B. Fuentes, M. Alonso de Leciñana, J. Campollo, P. Calleja Castaño, J. Carneado Ruiz, et al. (+11)
43 [GO] 2020―May―08 A neurology department at a tertiary-level hospital during the COVID-19 pandemic F. Grandas, J.M. García Domínguez, F. Díaz Otero
44 [GO] 2020―May―08 Fatal Guillain-Barre syndrome after infection with SARS-CoV-2 J. Marta-Enguita, I. Rubio-Baines, I. Gastón-Zubimendi
45 [GO] 2020―May―08 Guillain-Barré syndrome associated with SARS-CoV-2 infection A. Velayos Galán, P. del Saz Saucedo, F .Peinado Postigo, E. Botia Paniagua
46 [GO] 2020―May―08 Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: A delayed pandemic? P.J. Serrano-Castro, G. Estivill-Torrús, P. Cabezudo-García, J.A. Reyes-Bueno, N. Ciano Petersen, M.J. Aguilar-Castillo, et al. (+6)
47 [GO] 2020―May―06 SARS-CoV-2 infection associated with diplopia and anti-acetylcholine receptor antibodies Á.I. Pérez Álvarez, C. Suárez Cuervo, S. Fernández Menéndez
48 [GO] 2020―Apr―23 Management of neurological care during the COVID-19 pandemic J. Matías-Guiu, J. Porta-Etessam, E. Lopez-Valdes, I. Garcia-Morales, A. Guerrero-Solá, J.A. Matias-Guiu
49 [GO] 2020―Apr―17 Should we expect neurological symptoms in the SARS-CoV-2 epidemic? J. Matías-Guiu, U. Gomez-Pinedo, P. Montero-Escribano, P. Gomez-Iglesias, J. Porta-Etessam, J.A. Matias-Guiu


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.009 sec